These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7690773)

  • 21. Defective reticuloendothelial system C3b mediated clearance in rheumatoid arthritis and vasculitis.
    Cunningham TJ; Nicholls KM; Chen SL; Mathews JD; Muirden KD
    J Rheumatol; 1985 Aug; 12(4):675-9. PubMed ID: 4057188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells.
    Fossati-Jimack L; Ling GS; Cortini A; Szajna M; Malik TH; McDonald JU; Pickering MC; Cook HT; Taylor PR; Botto M
    PLoS One; 2013; 8(2):e57082. PubMed ID: 23451151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3.
    Krauss JC; PooH ; Xue W; Mayo-Bond L; Todd RF; Petty HR
    J Immunol; 1994 Aug; 153(4):1769-77. PubMed ID: 8046243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus].
    Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M
    Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V; Mahoney JA; Petri M
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis.
    MacPherson M; Lek HS; Prescott A; Fagerholm SC
    J Biol Chem; 2011 May; 286(19):17303-10. PubMed ID: 21454473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
    Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
    J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus.
    Agnello V; De Bracco MM; Kunkel HG
    J Immunol; 1972 Mar; 108(3):837-40. PubMed ID: 4110990
    [No Abstract]   [Full Text] [Related]  

  • 32. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles.
    Fällman M; Andersson R; Andersson T
    J Immunol; 1993 Jul; 151(1):330-8. PubMed ID: 8326130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis.
    Reichert F; Slobodov U; Makranz C; Rotshenker S
    Neurobiol Dis; 2001 Jun; 8(3):504-12. PubMed ID: 11442357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera.
    Grossmayer GE; Munoz LE; Weber CK; Franz S; Voll RE; Kern PM; Kalden JR; Schett G; Herrmann M; Gaipl US
    Ann Rheum Dis; 2008 Nov; 67(11):1626-32. PubMed ID: 18165321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis.
    Hellwig SM; van Oirschot HF; Hazenbos WL; van Spriel AB; Mooi FR; van De Winkel JG
    J Infect Dis; 2001 Mar; 183(6):871-9. PubMed ID: 11237803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
    J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.